Apertura Gene Therapy and Scientists from the Broad Institute to Share Data on TfR1 CapX™, a Novel Capsid Targeting the Central Nervous System (CNS), at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

B — Presentations show that TfR1 CapX™ is being manufactured at clinical scale, a major hurdle in gene therapy development, and illustrate the importance of human-relevant…
posteditor
posteditor
Articles: 21727

Other News